Avicanna Inc is a biopharmaceutical company that develops plant-derived cannabinoid-based products, says CEO Aras Azadian
In this interview from the 2019 Benzinga Cannabis Capital Conference in Toronto, SmallCapPower spoke with Aras Azadian, CEO of Avicanna Inc, a biopharmaceutical company that develops and manufacturers plant-derived cannabinoid-based products. Mr. Azadian discusses the Company’s Colombia advantage, its commercialization efforts, as well as Avicanna’s scientific and clinical leadership.
Ubika Research/SmallCapPower has received compensation from Avicanna to provide analyst research coverage. For full disclosure please visit here >>
To read our full disclosure, please click on the button below: